CellType is a Y Combinator W26 biotech startup building an 'agentic drug company' that simulates human biology to de-risk drug discovery. Founded by Yale professor David van Dijk and ML engineer Ivan Vrkic, it pairs Cell2Sentence, a 27-billion-parameter biological foundation model built with Google DeepMind, with AI agents that run the discovery pipeline from hypothesis to compound screening. The goal is to replace animal models and cell lines with computational simulations of human biology and cut preclinical failure rates.
DeepBrain AI is a generative-AI company that builds hyper-realistic digital humans. Its flagship platform, AI Studios, turns plain text scripts into professional avatar-led videos in minutes, while its AI Human technology powers real-time conversational avatars used in kiosks, virtual receptionists, banking, and AI news anchors. Founded in Seoul in 2016 and now operating from Palo Alto and beyond, the company serves enterprises across media, finance, education, and the public sector with tools that remove cameras, studios, and actors from video production.